BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 27549100)

  • 1. Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment.
    Naganuma M; Okuda S; Hisamatsu T; Matsuoka K; Mori K; Hosoe N; Nakazato Y; Ogata H; Kanai T
    Abdom Radiol (NY); 2017 Jan; 42(1):141-151. PubMed ID: 27549100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of anti-TNF therapy on the magnetic resonance enterographic parameters of Crohn's disease activity.
    Eder P; Katulska K; Krela-Kaźmierczak I; Stawczyk-Eder K; Klimczak K; Szymczak A; Linke K; Łykowska-Szuber L
    Abdom Imaging; 2015 Oct; 40(7):2210-8. PubMed ID: 26048698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn's disease: correlation with SES-CD and clinical-biological markers.
    Stoppino LP; Della Valle N; Rizzi S; Cleopazzo E; Centola A; Iamele D; Bristogiannis C; Stoppino G; Vinci R; Macarini L
    BMC Med Imaging; 2016 May; 16(1):37. PubMed ID: 27149857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Scanzi J; Goutorbe F; Klotz T; Boyer L; Pereira B; Bommelaer G
    Dig Liver Dis; 2016 Mar; 48(3):260-6. PubMed ID: 26699828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease.
    Ordás I; Rimola J; Rodríguez S; Paredes JM; Martínez-Pérez MJ; Blanc E; Arévalo JA; Aduna M; Andreu M; Radosevic A; Ramírez-Morros AM; Pinó S; Gallego M; Jauregui-Amezaga A; Ricart E; Panés J
    Gastroenterology; 2014 Feb; 146(2):374-82.e1. PubMed ID: 24177375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in dynamic contrast-enhanced pharmacokinetic and diffusion-weighted imaging parameters reflect response to anti-TNF therapy in Crohn's disease.
    Bhatnagar G; Dikaios N; Prezzi D; Vega R; Halligan S; Taylor SA
    Br J Radiol; 2015; 88(1055):20150547. PubMed ID: 26402217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
    Van Assche G; Herrmann KA; Louis E; Everett SM; Colombel JF; Rahier JF; Vanbeckevoort D; Meunier P; Tolan D; Ernst O; Rutgeerts P; Vermeire S; Aerden I; Oortwijn A; Ochsenkühn T
    J Crohns Colitis; 2013 Dec; 7(12):950-7. PubMed ID: 23411006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-Bowel Crohn Disease Treated With Anti-Tumor Necrosis Factor-α Therapy: MR Enterography Score Changes After 1 Year Predict Long-Term Outcomes.
    Gallego JC; de Juan C; Echarri A; Lopez-de-Ullibarri I
    AJR Am J Roentgenol; 2019 Dec; 213(6):1240-1246. PubMed ID: 31414894
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnetic resonance enterography findings as predictors of clinical outcome following antitumor necrosis factor treatment in small bowel Crohn's disease.
    Gibson DJ; Murphy DJ; Smyth AE; McEvoy SH; Keegan D; Byrne K; Mulcahy HE; Cullen G; Malone DE; Doherty GA
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):956-62. PubMed ID: 26049706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab Exposure Associates With Radiologic Evidence of Healing in Patients With Crohn's Disease.
    Bossuyt P; Dreesen E; Rimola J; Devuysere S; De Bruecker Y; Vanslembrouck R; Laurent V; Zappa M; Savoye-Collet C; Pariente B; Filippi J; Baert F; D'Haens G; Laharie D; Peyrin-Biroulet L; Vermeire S;
    Clin Gastroenterol Hepatol; 2021 May; 19(5):947-954.e2. PubMed ID: 32360982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent damage on magnetic resonance enterography in patients with Crohn's disease in endoscopic remission.
    Rimola J; Alfaro I; Fernández-Clotet A; Castro-Poceiro J; Vas D; Rodríguez S; Masamunt MC; Ordás I; Ricart E; Panés J
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1232-1241. PubMed ID: 30345577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures.
    Schulberg JD; Wright EK; Holt BA; Sutherland TR; Hume SJ; Hamilton AL; Ross AL; Connell WC; Brown SJ; Lust M; Miller AM; Bell SJ; Kamm MA
    J Gastroenterol Hepatol; 2020 Jun; 35(6):980-987. PubMed ID: 31674069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment magnetic resonance enterography findings predict the response to TNF-alpha inhibitors in Crohn's disease.
    Rimola J; Fernàndez-Clotet A; Capozzi N; Rojas-Farreras S; Alfaro I; Rodríguez S; Masamunt MC; Ricart E; Ordás I; Panés J
    Aliment Pharmacol Ther; 2020 Nov; 52(10):1563-1573. PubMed ID: 32886809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.
    Thomassin L; Armengol-Debeir L; Charpentier C; Bridoux V; Koning E; Savoye G; Savoye-Collet C
    World J Gastroenterol; 2017 Jun; 23(23):4285-4292. PubMed ID: 28694669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn's disease.
    Alfaro I; Masamunt MC; Planell N; López-García A; Castro J; Gallego M; Barastegui R; Giner A; Vara A; Salas A; Ricart E; Panés J; Ordás I
    World J Gastroenterol; 2019 Apr; 25(14):1764-1774. PubMed ID: 31011260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Takenaka K; Ohtsuka K; Kitazume Y; Matsuoka K; Nagahori M; Fujii T; Saito E; Kimura M; Fujioka T; Watanabe M
    Am J Gastroenterol; 2018 Feb; 113(2):283-294. PubMed ID: 29257147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic accuracy of intestinal ultrasound and magnetic resonance enterography for the detection of endoscopy-based disease activity in ileocolonic Crohn's disease.
    Yuksel I; Kilincalp S; Coskun Y; Akinci H; Hamamci M; Alkan A
    Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):809-816. PubMed ID: 31094855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Transmural Response Assessed Using Magnetic Resonance Imaging Could Predict Sustained Clinical Remission and Prevent Bowel Damage in Patients with Crohn's Disease Treated with Anti-Tumour Necrosis Factor Therapy.
    Messadeg L; Hordonneau C; Bouguen G; Goutorbe F; Reimund JM; Goutte M; Boucher AL; Scanzi J; Reymond M; Allimant C; Dapoigny M; Pereira B; Bommelaer G; Buisson A
    J Crohns Colitis; 2020 Nov; 14(11):1524-1534. PubMed ID: 32533769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of Surveillance MR Enterography (MRE) in Asymptomatic Children and Adolescents With Crohn's Disease.
    Chu KF; Moran CJ; Wu K; Kaplan JL; Savarino JR; Board T; Israel EJ; Winter HS; Gee MS
    J Magn Reson Imaging; 2019 Dec; 50(6):1955-1963. PubMed ID: 31145502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic Severity Predicts Long-Term Prognosis in Crohn's Disease Patients with Clinical Remission.
    Naganuma M; Hisamatsu T; Matsuoka K; Kiyohara H; Arai M; Sugimoto S; Mori K; Nanki K; Ohno K; Mutaguchi M; Mizuno S; Bessho R; Nakazato Y; Hosoe N; Inoue N; Iwao Y; Ogata H; Kanai T
    Digestion; 2016; 93(1):66-71. PubMed ID: 26789838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.